164 related articles for article (PubMed ID: 35174471)
1. Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1.
Wang G; Zhuang Z; Shen S; Yang F; Jiang Z; Liu Z; Wang T; Hua L
Hum Cell; 2022 May; 35(3):896-908. PubMed ID: 35174471
[TBL] [Abstract][Full Text] [Related]
2. ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity.
Ali R; Alabdullah M; Miligy I; Normatova M; Babaei-Jadidi R; Nateri AS; Rakha EA; Madhusudan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31635307
[TBL] [Abstract][Full Text] [Related]
3. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
Yu S; Dai J; Ma M; Xu T; Kong Y; Cui C; Chi Z; Si L; Tang H; Yang L; Sheng X; Guo J
Cell Death Dis; 2019 Mar; 10(4):254. PubMed ID: 30874541
[TBL] [Abstract][Full Text] [Related]
4. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.
Xu H; Ju L; Xiong Y; Yu M; Zhou F; Qian K; Wang G; Xiao Y; Wang X
Cell Death Dis; 2021 Mar; 12(3):239. PubMed ID: 33664240
[TBL] [Abstract][Full Text] [Related]
5. p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.
Hong SW; Moon JH; Kim JS; Shin JS; Jung KA; Lee WK; Jeong SY; Hwang JJ; Lee SJ; Suh YA; Kim I; Nam KY; Han S; Kim JE; Kim KP; Hong YS; Lee JL; Lee WJ; Choi EK; Lee JS; Jin DH; Kim TW
Cell Death Differ; 2014 Jan; 21(1):146-60. PubMed ID: 24141722
[TBL] [Abstract][Full Text] [Related]
6. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
[TBL] [Abstract][Full Text] [Related]
7. PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
Zheng F; Zhong J; Chen K; Shi Y; Wang F; Wang S; Tang S; Yuan X; Shen Z; Tang S; Xia D; Wu Y; Lu W
J Exp Clin Cancer Res; 2023 Nov; 42(1):295. PubMed ID: 37940999
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells.
Zhang Y; Lu Y; Xu Y; Le Z; Liu Y; Tu W; Liu Y
Life Sci; 2023 May; 321():121594. PubMed ID: 36934971
[TBL] [Abstract][Full Text] [Related]
9. RBCK1, an E3 ubiquitin ligase, interacts with and ubiquinates the human pregnane X receptor.
Rana R; Coulter S; Kinyamu H; Goldstein JA
Drug Metab Dispos; 2013 Feb; 41(2):398-405. PubMed ID: 23160820
[TBL] [Abstract][Full Text] [Related]
10. Anti-oncogenic PTEN induces ovarian cancer cell senescence by targeting P21.
Ke X; Li L; Li J; Zheng M; Liu P
Cell Biol Int; 2022 Jan; 46(1):118-128. PubMed ID: 34643308
[TBL] [Abstract][Full Text] [Related]
11. The HECT family of E3 ubiquitin ligases and PTEN.
Song MS; Pandolfi PP
Semin Cancer Biol; 2022 Oct; 85():43-51. PubMed ID: 34129913
[TBL] [Abstract][Full Text] [Related]
12. Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3.
Zhang M; Tian Y; Wang RP; Gao D; Zhang Y; Diao FC; Chen DY; Zhai ZH; Shu HB
Cell Res; 2008 Nov; 18(11):1096-104. PubMed ID: 18711448
[TBL] [Abstract][Full Text] [Related]
13. The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation.
Ahmed SF; Deb S; Paul I; Chatterjee A; Mandal T; Chatterjee U; Ghosh MK
J Biol Chem; 2012 May; 287(19):15996-6006. PubMed ID: 22427670
[TBL] [Abstract][Full Text] [Related]
14. Identification of ubiquitin ligase activity of RBCK1 and its inhibition by splice variant RBCK2 and protein kinase Cbeta.
Tatematsu K; Yoshimoto N; Okajima T; Tanizawa K; Kuroda S
J Biol Chem; 2008 Apr; 283(17):11575-85. PubMed ID: 18303026
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer.
Wang K; Liu J; Li YL; Li JP; Zhang R
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188723. PubMed ID: 35314212
[TBL] [Abstract][Full Text] [Related]
16. HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression.
Liu L; Long H; Wu Y; Li H; Dong L; Zhong JL; Liu Z; Yang X; Dai X; Shi L; Ren M; Lin Z
Cell Signal; 2018 Oct; 50():90-99. PubMed ID: 29958993
[TBL] [Abstract][Full Text] [Related]
17. RBCK1 overexpression is associated with immune cell infiltration and poor prognosis in hepatocellular carcinoma.
Yu J; Liu T; Liu M; Jin H; Wei Z
Aging (Albany NY); 2024 Jan; 16(1):538-549. PubMed ID: 38214606
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
[TBL] [Abstract][Full Text] [Related]
19. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
20. Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.
Shao C; Li Z; Ahmad N; Liu X
Cell Cycle; 2017 May; 16(10):957-967. PubMed ID: 28437168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
